The RITMO (Registro Italiano sul trattamento del Tronco coMune non protettO) observational study will appraise the prevalence, management strategy, and prognosis of unprotected left main coronary artery disease in Italy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
major adverse cerebro-cardiovascular events (ie death, myocardial infarction, stroke, or coronary revascularization)
Timeframe: 12 months